ClinicalTrials.Veeva

Menu

GORE Flow Reversal System and GORE Embolic Filter Extension Study (FREEDOM)

W.L. Gore & Associates logo

W.L. Gore & Associates

Status

Completed

Conditions

Constriction, Pathologic
Carotid Stenosis
Arterial Occlusive Diseases
Central Nervous System Diseases
Cardiovascular Diseases
Nervous System Diseases
Vascular Diseases
Cerebrovascular Disorders
Pathological Conditions, Anatomical
Brain Diseases
Carotid Artery Diseases

Treatments

Device: Gore Embolic Filter
Device: Gore Flow Reversal System

Study type

Interventional

Funder types

Industry

Identifiers

NCT01343667
FRS 09-05

Details and patient eligibility

About

The objective of this study is to provide an ongoing evaluation of clinical outcomes associated with the GORE Flow Reversal System and the GORE Embolic Filter when used for embolic protection during carotid artery stenting.

Full description

Physicians will have the opportunity to select which embolic protection device, the GORE Flow Reversal System or the GORE Embolic Filter, to use during the carotid artery stenting procedure.

This study is not designed to compare study endpoints between the two treatment arms.

Enrollment

1,397 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient, or patient's legal representative, is able and willing to provide informed consent.
  • Patient must be at least 18 years of age or older.
  • Patient will be selected and treated according to the GORE Flow Reversal System Instructions for Use (IFU) or the GORE Embolic Filter IFU.

Exclusion criteria

  • Patient is contraindicated for the embolic protection device arm they are selected by the investigator to receive: Either Per the GORE Flow Reversal System IFU if the GORE Flow Reversal System is selected OR Per the GORE Embolic Filter IFU if the GORE Embolic Filter is selected

If the patient is contraindicated for both arms (devices) they may not be enrolled.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,397 participants in 2 patient groups

GFRS EPD
Other group
Description:
Carotid artery stenting with Gore Flow Reversal System embolic protection device
Treatment:
Device: Gore Flow Reversal System
GEF EPD
Other group
Description:
Carotid artery stenting with Gore Embolic Filter embolic protection device
Treatment:
Device: Gore Embolic Filter

Trial contacts and locations

39

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems